Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group
June 3, 2024 | Clinical Journal of the American Society of Nephrology
Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S. Bomback, Fernando Caravaca-Fontán, Terence H. Cook, David L. Feldman, Veronique Fremeaux-Bacchi, Daniel P. Gale, Ann Gooch, Sally Johnson, Christoph Licht, Mohit Mathur, Matthew C. Pickering, Manuel Praga, Giuseppe Remuzzi, Viknesh Selvarajah, Richard J. Smith, Hossein Tabriziani, Nicole van de Kar, Yaqin Wang, Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun, Howard Trachtman, Aliza Thompson